AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

INVION LTD

0.034

-0.004-10.53%

Volume:204.82K

Turnover:7K

Market Cap:3.71M

PE:-0.54

High:0.037

Open:0.037

Low:0.034

Close:0.038

52wk High:0.110

52wk Low:0.032

Shares:109.20M

Float Shares:56.74M

Volume Ratio:6.37

T/O Rate:0.36%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.063

EPS(LYR):-0.063

ROE:-83.02%

ROA:-40.10%

PB:0.70

PE(LYR):-0.54

Loading ...

Overview Company News Filings

Company Profile

Company Name:

INVION LTD

Exchange:

ASX

Establishment Date:

2000

Employees:

4

Office Location:

385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia

Website:

http://www.inviongroup.com

Zip Code:

3000

Phone:

Fax:

- -

Introduction:

Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigerhkgo.com/stock/IVX.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IVX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","market":"AU","secType":"STK","nameCN":"INVION LTD","latestPrice":0.034,"timestamp":1791770350663,"preClose":0.038,"halted":0,"volume":204823,"delay":0,"changeRate":-0.10526315789473675,"nameEN":"INVION LTD","floatShares":56741426,"shares":109200637,"eps":-0.0626,"marketStatus":"Trading","change":-0.004,"latestTime":"10-12 14:53:05 AEDT","open":0.037,"high":0.037,"low":0.034,"amount":7465,"amplitude":0.078947,"askPrice":0.037,"askSize":11381,"bidPrice":0.034,"bidSize":10603,"shortable":3,"etf":0,"ttmEps":-0.0626,"tradingStatus":2,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791781200000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.038,"openAndCloseTimeList":[[1791759600000,1791781200000]],"volumeRatio":6.371656,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"IVX.AU","preClose":0.038,"auctionPrice":0.037,"auctionVolume":258,"auctionTime":1791757995360,"referenceTime":1790937003087,"auction":1,"marketStatus":"盘前竞价","timestamp":1791757995360}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"IVX.AU\",,,,,undefined,":{"symbol":"IVX.AU","floatShares":56741426,"roa":"-40.10%","roe":"-83.02%","lyrEps":-0.0626,"volumeRatio":6.371656,"shares":109200637,"dividePrice":0,"high":0.037,"amplitude":0.078947,"preClose":0.038,"low":0.034,"week52Low":0.032,"pbRate":"0.70","psRate":"9.65","week52High":0.11,"institutionHeld":0,"latestPrice":0.034,"committee":-0.035389,"eps":-0.0626,"divideRate":0,"volume":204823,"delay":0,"ttmEps":-0.0626,"open":0.037,"prevYearClose":0.093,"prevWeekClose":0.038,"prevMonthClose":0.037,"prevQuarterClose":0.037,"fiveDayClose":0.042,"twentyDayClose":0.045,"sixtyDayClose":0.041},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IVX.AU\",params:#limit:5,,,undefined,":[{"market":"AU","date":"2024-11-20","symbol":"IVX.AU","defaultRemindTime":1732057200000,"type":"split","dateTimestamp":1732021200000,"forFactor":100,"toFactor":1,"ratio":100}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":[],"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":28625535,"yearFounded":2000,"employeeNum":4,"address":"385 Bourke Street,Suite 2, Level 11,Melbourne,Victoria,Australia","zipCode":"3000","officePhone":"61 3 9692 7222","fiscalYearEnd":"06-30"},"stockCompanyDetail":{"websiteUrl":"http://www.inviongroup.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1163},{"period":"3month","weight":0.027},{"period":"6month","weight":-0.4328},{"period":"1year","weight":-0.62},{"period":"ytd","weight":-0.5914}],"compareEarnings":[{"period":"1week","weight":0.0007},{"period":"1month","weight":-0.0099},{"period":"3month","weight":-0.0086},{"period":"6month","weight":0.0071},{"period":"1year","weight":0.0641},{"period":"ytd","weight":0.0233}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Invion Limited, a clinical-stage life-sciences company, develops photodynamic therapy for the treatment of various cancers in Australia. It develops IVX-P02 to treat skin cancers, as well as solid cancers, including lung, prostrate, and ovarian cancers; and IVX-MES, an intravenous treatment for mesothelioma. The company has a research and development alliance agreement with Hudson Institute of Medical Research to collaborate on a range of research and development projects for the Photosoft technology for the treatment of a range of cancers; and partnership agreements with Formulytica and vivoPharm to develop and test IVX-P02 gel. Invion Limited also has a research agreement with Peter MacCallum Cancer Centre to undertake pre-clinical and in-vitro studies on Invion's IVX-PDT Photodynamic therapy for ano-genital cancers, including penile and anal cancer. The company is headquartered in Melbourne, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.1875,"avgChangeRate":-0.041711},{"month":2,"riseRate":0.411765,"avgChangeRate":0.101718},{"month":3,"riseRate":0.235294,"avgChangeRate":0.002839},{"month":4,"riseRate":0.176471,"avgChangeRate":-0.044147},{"month":5,"riseRate":0.235294,"avgChangeRate":-0.095613},{"month":6,"riseRate":0.588235,"avgChangeRate":0.122774},{"month":7,"riseRate":0.235294,"avgChangeRate":-0.041549},{"month":8,"riseRate":0.235294,"avgChangeRate":0.045734},{"month":9,"riseRate":0.352941,"avgChangeRate":0.005699},{"month":10,"riseRate":0.4375,"avgChangeRate":-0.041413},{"month":11,"riseRate":0.3125,"avgChangeRate":-0.053558},{"month":12,"riseRate":0.375,"avgChangeRate":0.119438}],"exchange":"ASX","name":"INVION LTD","nameEN":"INVION LTD"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IVX.AU\",market:\"AU\",,,undefined,":null}}